The classic website will no longer be available as of June 25, 2024. Please use the modernized
Working… Menu

ProBio: A Biomarker Driven Study in Patients With Metastatic Prostate Cancer (ProBio)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details. Identifier: NCT03903835
Recruitment Status : Recruiting
First Posted : April 4, 2019
Last Update Posted : January 17, 2024
The Swedish Research Council
Kom Op Tegen Kanker
Janssen Pharmaceutica N.V., Belgium
Information provided by (Responsible Party):
Henrik Grönberg, Karolinska Institutet